C
Catherine Stevens
Researcher at Merck & Co.
Publications - 4
Citations - 822
Catherine Stevens is an academic researcher from Merck & Co.. The author has contributed to research in topics: Sitagliptin & Sitagliptin Phosphate. The author has an hindex of 4, co-authored 4 publications receiving 785 citations.
Papers
More filters
Journal ArticleDOI
Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes
Gary A. Herman,Arthur J. Bergman,Catherine Stevens,Paul Kotey,Bingming Yi,Peng Zhao,Bruno Dietrich,George Golor,Andreas Schrodter,Bart Keymeulen,Kenneth C. Lasseter,Mark Kipnes,Karen Snyder,Deborah Hilliard,Michael Tanen,Caroline Cilissen,Marina De Smet,Inge De Lepeleire,Kristien Van Dyck,Amy Qiu Wang,Wei Zeng,Michael J. Davies,Wesley Tanaka,Jens J. Holst,Carolyn F. Deacon,Keith Gottesdiener,John A. Wagner +26 more
TL;DR: In patients with type 2 diabetes, near maximal glucose-lowering efficacy of sitagliptin after single oral doses was associated with inhibition of plasma DPP-4 activity of 80% or greater, corresponding to a plasma sitgliptin concentration of 100 nm or greater and an augmentation of active GLP-1 and GIP levels of 2-fold or higher after an OGTT.
Journal ArticleDOI
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Arthur J. Bergman,Catherine Stevens,YanYan Zhou,Bingming Yi,Martine Laethem,Marina De Smet,Karen Snyder,Deborah Hilliard,Wesley Tanaka,Wei Zeng,Michael Tanen,Amy Qiu Wang,Li Chen,Gregory A. Winchell,Michael J. Davies,Steven Ramael,John A. Wagner,Gary A. Herman +17 more
TL;DR: Assessment of the pharmacokinetic and pharmacodynamic properties and tolerability of multiple oral once-daily or twice-daily doses of sitagliptin found a finding consistent with near-maximal acute glucose lowering in preclinical studies.
Journal Article
Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin.
Elizabeth Migoya,Catherine Stevens,Arthur J. Bergman,Wen-Lin Luo,Kenneth C. Lasseter,Stacy C. Dilzer,Michael J. Davies,John A. Wagner,Gary A. Herman +8 more
TL;DR: Moderate hepatic insufficiency has no clinically meaningful effect on the pharmacokinetics of sitagliptin and the drug was generally well tolerated by both patients and subjects.
Journal ArticleDOI
Lack of erectogenic activity of a novel selective melanocortin-4 receptor agonist in a clinical experimental model.
Rajesh Krishna,Peggy H. Wong,Catherine Stevens,Inge De Lepeleire,Kristien Van Dyck,Raymond C. Rosen,I.N. Gendrano,Mathieu Peeters,John A. Wagner,Gary A. Herman +9 more